Vir Biotechnology, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
SB INVESTMENT ADVISERS (UK) LTD | 11/14/2024 | 16.68 M | $124.96 M | 0.00% | 12.21% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 16.38 M | $122.65 M | 100.00% | 11.98% |
VANGUARD GROUP INC | 11/13/2024 | 13.14 M | $98.39 M | 2.23% | 9.61% |
STATE STREET CORP | 11/14/2024 | 5.63 M | $42.14 M | 10.42% | 4.12% |
ORBIMED ADVISORS LLC | 11/14/2024 | 3.57 M | $26.76 M | 54.00% | 2.61% |
BAILLIE GIFFORD & CO | 11/05/2024 | 2.38 M | $17.85 M | -39.23% | 1.74% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 2.19 M | $16.40 M | 0.24% | 1.60% |
BILL & MELINDA GATES FOUNDATION | 11/14/2024 | 1.56 M | $11.68 M | 0.00% | 1.14% |
MORGAN STANLEY | 11/14/2024 | 1.24 M | $9.26 M | -41.74% | 0.91% |
DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 1.21 M | $9.08 M | 90.14% | 0.89% |
RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 1.18 M | $8.86 M | -11.09% | 0.87% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 1.13 M | $8.50 M | 13.63% | 0.83% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 1.10 M | $8.27 M | -11.49% | 0.81% |
JPMORGAN CHASE & CO | 11/08/2024 | 1.09 M | $8.14 M | -13.46% | 0.79% |
JEFFERIES FINANCIAL GROUP INC. | 11/14/2024 | 1.09 M | $8.13 M | 100.00% | 0.79% |
JEFFERIES FINANCIAL GROUP INC. | 11/14/2024 | 1.09 M | $8.13 M | 100.00% | 0.79% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 975,300 | $7.30 M | -20.38% | 0.71% |
D. E. SHAW & CO., INC. | 11/14/2024 | 930,655 | $6.97 M | 0.88% | 0.68% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 832,683 | $6.24 M | 6.37% | 0.61% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 642,283 | $4.81 M | -21.03% | 0.47% |
BARCLAYS PLC | 11/19/2024 | 550,186 | $4.12 M | 1.34% | 0.40% |
HUDSON BAY CAPITAL MANAGEMENT LP | 11/13/2024 | 528,242 | $3.96 M | 24.29% | 0.39% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 521,863 | $3.91 M | 141.37% | 0.38% |
PRINCIPAL FINANCIAL GROUP INC | 10/31/2024 | 431,411 | $3.23 M | -0.74% | 0.32% |
NORDEA INVESTMENT MANAGEMENT AB | 11/05/2024 | 423,087 | $3.24 M | 53.55% | 0.31% |
INVESCO LTD. | 11/12/2024 | 396,198 | $2.97 M | -4.78% | 0.29% |
UBS GROUP AG | 11/14/2024 | 383,188 | $2.87 M | 30.57% | 0.28% |
QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 358,086 | $2.68 M | 1,295.23% | 0.26% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 350,265 | $2.62 M | 10.57% | 0.26% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 336,593 | $2.52 M | -60.48% | 0.25% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 329,781 | $2.47 M | -58.19% | 0.24% |
EMPOWERED FUNDS, LLC | 11/06/2024 | 329,781 | $2.47 M | -33.18% | 0.24% |
ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 319,185 | $2.39 M | 190.17% | 0.23% |
CI PRIVATE WEALTH, LLC | 11/12/2024 | 283,065 | $2.12 M | 6.38% | 0.21% |
TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 276,024 | $2.07 M | -22.58% | 0.20% |
CITADEL ADVISORS LLC | 11/14/2024 | 268,972 | $2.01 M | -64.14% | 0.20% |
AMERIPRISE FINANCIAL INC | 11/14/2024 | 267,414 | $2.00 M | -13.28% | 0.20% |
LEGAL & GENERAL GROUP PLC | 11/14/2024 | 258,936 | $1.94 M | 0.94% | 0.19% |
WELLS FARGO & COMPANY/MN | 11/13/2024 | 251,757 | $1.89 M | 493.54% | 0.18% |
RHUMBLINE ADVISERS | 11/12/2024 | 235,393 | $1.76 M | -1.30% | 0.17% |
PDT PARTNERS, LLC | 11/14/2024 | 220,821 | $1.65 M | 34.38% | 0.16% |
ALGERT GLOBAL LLC | 11/12/2024 | 213,465 | $1.60 M | 27.95% | 0.16% |
AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 206,889 | $1.55 M | 22.98% | 0.15% |
TREXQUANT INVESTMENT LP | 11/12/2024 | 196,991 | $1.48 M | 92.56% | 0.14% |
PUBLIC SECTOR PENSION INVESTMENT BOARD | 11/14/2024 | 194,208 | $1.45 M | 1.36% | 0.14% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2024 | 189,670 | $1.42 M | -13.46% | 0.14% |
SWISS NATIONAL BANK | 11/07/2024 | 185,200 | $1.39 M | 0.00% | 0.14% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2024 | 174,740 | $1.31 M | -7.36% | 0.13% |
RAFFERTY ASSET MANAGEMENT, LLC | 11/13/2024 | 173,852 | $1.30 M | 19.20% | 0.13% |
STATE OF ALASKA, DEPARTMENT OF REVENUE | 10/24/2024 | 152,242 | $1.14 M | 0.74% | 0.11% |
Vir Biotechnology, Inc.institutional Ownership - FAQ's
During the previous two years, 255 institutional investors and hedge funds held shares of Vir Biotechnology, Inc.. The most heavily invested institutionals were:
SB INVESTMENT ADVISERS (UK) LTD: 16.68 M
BlackRock Funding, Inc. /DE: 16.38 M
VANGUARD GROUP INC: 13.14 M
STATE STREET CORP: 5.63 M
ORBIMED ADVISORS LLC: 3.57 M
BAILLIE GIFFORD & CO: 2.38 M
64.11% of Vir Biotechnology, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 103.10 M shares in the last 24 months. This purchase volume represents approximately $753.68 M in transactions.